LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC

Tina Cascone, Mark M. Awad, J.D. Spicer, Jie He, Shun Lü, Boris Sepesi, Fumihiro Tanaka, Janis M. Taube, Robin Cornelissen, Libor Havel, J. Kuzdzal, Luboš Petruželka, Lin Wu, J-L. Pujol, Hiroyuki Ito, C. Coronado Erdmann, Padma Sathyanarayana, S. Meadows–Shropshire, M. Provencio Pulla